Nitric Oxide (NO) – Electronic Grade for Semiconductor & Medical Use
Global MArket Overview
Production and Pricing
NOis produced by catalytic oxidation of Ammonia or by reacting sodium nitrite with sulfuric acid.High-purity NO commands prices of $300–$500 per kg, depending on purity and packaging. The electronic-grade segment is the fastest-growing, with Asia-Pacific accounting for 60% of demand.
Key Applications
Semiconductor Doping and Oxidation
In semiconductor fabs, electronic-grade NO is used as a doping gas for silicon carbide (SiC) and gallium nitride (GaN) power devices. It also serves as an oxidizing agent for thin gate oxide formation. With the SiC power device market growing at 25% CAGR (driven by EV inverters), NO demand is surging.
Medical Inhalation Therapy
Inhaled nitric oxide is a vasodilator used to treat hypoxic respiratory failure in newborns and pulmonary hypertension in adults. The medical NO market is regulated and requires certified mixtures (typically 800 ppm in nitrogen). Global adoption is increasing, particularly in China and India.
Calibration and Environmental Monitoring
NO calibration mixtures are essential for emissions testing (automotive and stack monitoring). Stringent NOx limits (e.g., Euro 7, China 7) require accurate calibration gases.
Market Drivers in 2026
-
Expansion of Power Semiconductor Fabs: Investments in SiC and GaN fabs (e.g., Wolfspeed, STMicroelectronics, Infineon) directly boost NO consumption.
-
Increasing Use in Neonatal Care: More hospitals in emerging economies are adopting inhaled NO therapy.
-
Stringent NOx Emission Standards: New regulations in Europe and Asia drive demand for NO calibration gases.
Why Choose Chengdu Hongjin Chemical?
We supply 99.999% electronic-grade NO with moisture <2 ppm and total impurities <10 ppm. Cylinders range from 2L to 47L. We also offer custom NO/N₂ mixtures.
👉 View our nitric oxide product page for data sheets.
Future Outlook
The electronic-grade NO segment will see double-digit growth through 2030, closely tied to SiC and GaN device production. The medical segment will grow steadily as generics lower costs. Total market expected to exceed $450 million by 2032.











